Work

The CBM signalosome: Potential therapeutic target for aggressive lymphoma?

Year: 2013

Type: review

Source: Cytokine & Growth Factor Reviews

DOI: 10.1016/j.cytogfr.2013.12.008

Authors: Chenghua Yang, Liron David, Qi Qiao, Ermelinda Damko, Hao Wu

Institutions: Memorial Sloan Kettering Cancer Center, Second Military Medical University, Changhai Hospital, Boston Children's Hospital, Harvard University, Weill Cornell Medicine, Cornell University

Language: English

Topic: NF-κB Signaling Pathways

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Cancer Research Institute, National Institute of Allergy and Infectious Diseases

Award: G4478249544

OpenAlex ID: W2157600092

FWCI: 0.096

Cites: 66

Cited by: 17

Related to: 10